BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 16880237)

  • 1. Hairy cell leukemia: an elusive but treatable disease.
    Wanko SO; de Castro C
    Oncologist; 2006; 11(7):780-9. PubMed ID: 16880237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M; Machaczka M; Załuska A; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hairy cell leukemia: current concepts.
    Cannon T; Mobarek D; Wegge J; Tabbara IA
    Cancer Invest; 2008 Oct; 26(8):860-5. PubMed ID: 18798068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current treatment options in hairy cell leukemia and hairy cell leukemia variant.
    Robak T
    Cancer Treat Rev; 2006 Aug; 32(5):365-76. PubMed ID: 16781083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab.
    Hensel M; Ho AD
    Am J Hematol; 2003 May; 73(1):37-40. PubMed ID: 12701118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
    Else M; Ruchlemer R; Osuji N; Del Giudice I; Matutes E; Woodman A; Wotherspoon A; Swansbury J; Dearden C; Catovsky D
    Cancer; 2005 Dec; 104(11):2442-8. PubMed ID: 16245328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
    Kraut EH
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recurrent somatic mutation in hairy cell leukemia].
    Sári E; Nagy Z; Demeter J
    Orv Hetil; 2013 Jan; 154(4):123-7. PubMed ID: 23335721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. My treatment approach to hairy cell leukemia.
    Naik RR; Saven A
    Mayo Clin Proc; 2012 Jan; 87(1):67-76. PubMed ID: 22212971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cladribine in hairy cell leukemia.
    Belani R; Saven A
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hairy cell leukaemia, its therapy and prognosis (historical review with own experiences).
    Chrobák L; Podzimek K; Zak P; Plísková L; Voglová J
    Acta Haematol Pol; 1995; 26(2 Suppl 1):56-62. PubMed ID: 7653236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hairy-cell leukemia: current views.
    Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A
    Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disease with hope: hairy cell leukemia.
    Becker SE
    Clin J Oncol Nurs; 2007 Oct; 11(5):731-5. PubMed ID: 17962181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
    Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hairy cell leukemia 1992.
    Spielberger RT; Golomb HM
    Leukemia; 1992 Nov; 6 Suppl 4():142-6. PubMed ID: 1279327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which role for rituximab in hairy cell leukemia? Reflections on six cases.
    Malfuson JV; Fagot T; Konopacki J; Souleau B; Cremades S; de Revel T
    Acta Haematol; 2010; 123(2):110-6. PubMed ID: 20051682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab as treatment for minimal residual disease in hairy cell leukaemia.
    Cervetti G; Galimberti S; Andreazzoli F; Fazzi R; Cecconi N; Caracciolo F; Petrini M
    Eur J Haematol; 2004 Dec; 73(6):412-7. PubMed ID: 15522063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia].
    Araki H; Matsunaga T; Murase K; Kuroda H; Kuribayashi K; Terui T; Niitsu Y
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):965-9. PubMed ID: 15222122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.